首页> 中文期刊> 《当代医学》 >醒脑静注射液在老年患者谵妄中的临床应用

醒脑静注射液在老年患者谵妄中的临床应用

         

摘要

目的:观察醒脑静注射液对老年患者全麻腹部手术术后谵妄的疗效。方法80例确诊为术后谵妄的患者随机分成醒脑静组(X组)和对照组(F组),每组40例,并对治疗前及用药后12 h、24 h、72 h进行Mini-Mental State(MMS)测式方法评定和谵妄发生时及用药后第1天S 100β蛋白的测定。结果两组在发生谵妄时MMS评分和S 100β蛋白的含量无显著差异(P>0.05),X组治疗24 h后MMS评分明显高于治疗前,同时也明显高于F组(P<0.05);F组治疗72 h后MMS较治疗前明显升高。同时,治疗24 h后X组S 100β蛋白明显低于F组(P<0.05)。结论醒脑静注射液可改善术后谵妄症状,可能与其有效抑制S 100β蛋白,保护脑细胞有关。%Objective To observe effects of Xingnaojing injection on postoperative delirium of old patients. Methods 80 patients suffering from postoperative delirium were randomly divided into Group X (which to be treated with Xingnaojing injection and Group F(which to be treated with haloperidol ). Every patients were diagnosed with Mini-Mental State(MMS), and MMS scores before treatment and subsequent 12, 24,72 hours were recorded. Meantime, level of protein S 100βwas measured. Results After treated with Xingnaojing injection 24 hours, MMS scores of Group X were increased obviously, while scores of Group C were stable until treated 72 hours later (P<0.05). Simultaneously, concentrations of protein S 100βof Group X were obviously lower than Group C after treated 24 hours (P<0.05). Conclusion Xingnaojing injection would improve brain function of postoperative delirium, which may be related to decreasing protein S 100βand then protecting brain cells.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号